Trans-hexahydrobenzoaphenanthridines of the formula (I) wherein X, Y, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, and R
7
are as defined herein, are disclosed. Pharmaceutical formulations including such compounds, and methods of using such compounds for treating a patient suffering from dopamine-related dysfunction of the central or peripheral nervous system are also disclosed.
本文披露了式(I)的跨六
氢苯并
苯并
哌啶,其中X、Y、R1、R2、R3、R4、R5、R6和R7如本文所定义。还披露了包括这些化合物的制药配方,以及使用这些化合物治疗中枢或外周神经系统
多巴胺相关功能障碍的患者的方法。